| ID ▼ | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 1404 | Heredit. hemochromatose | EDTA |
– | – | – | › | ||||
| 1344 | Anti-Xa Apixaban | Citraat |
maandag t/m vrijdag | 18 (0,7) | – | 74214-8 ng/mL | – | › | ||
| 1343 | anti-Xa Rivaroxaban Anti-Xa (New Oral AntiCoagulants) | Citraat |
1× per week | – | 74871-5 ng/mL | – | › | |||
| 1342 | anti-factor Xa | Citraat |
1× per week | 96 (4) | – | 3216-9 IU/ml | – | › | ||
| 1313 | Antithrombine (dier) | Citraat |
maandag t/m vrijdag | 67 (2,8) | – | – % | – | › | ||
| 1296 | Factor XIII screening | Citraat |
– | 3239-1 | – | › | ||||
| 1294 | Factor XII dosage Hageman Factor | Citraat |
– | 3232-6 % | – | › | ||||
| 1292 | Factor XI dosage | Citraat |
1× per 2 weken | 422 (17,6) | – | 3226-8 % | – | › | ||
| 1281 | von Willebrand (dier) Factor VIII gerelateerd antigen, Von Willebrand antigen, vWF Ag | Citraat |
3 (0,1) | – | – % | – | › | |||
| 1280 | Factor VIII (dier) | Citraat |
zelden, minder dan 1× per maand | 3 (0,1) | – | – % | – | › | ||
| 1274 | Factor VII dosage Proconvertine | Citraat |
1× per 2 weken | 521 (21,7) | – | 3198-9 % | – | › | ||
| 1272 | Factor V dosage | Citraat |
tenminste 1× per week | 218 (9,1) | – | 3193-0 % | – | › | ||
| 1270 | Factor II dosage | Citraat |
1× per 2 weken | – | 3289-6 % | – | › | |||
| 1254 | alfa 1 glycoproteine | Serum |
2× per week | – | – µg/mL | – g/L | › | |||
| 903 | FSH (M/V) | Serum |
– | – U/L | – | › |
